Sie sind hier: Programm > Thursday, Dec. 1st, 2016

PROGRAMME THURSDAY

► Carotid    ► Aortic    ► Peripheral artery disease    ► Poster Session    ► Workshop/Seminar    ► Venous
 
Lecture Hall B
 

09.00-10.00

MCC 1
Asymptomatic carotid stenosis I: update on randomized clinical trials

 

Chairs:
L. Bonati, Switzerland
H. Sillesen, Denmark

ACST-2 Update: Over 2300 asymptomatic patients randomised to CEA vs CAS – Progress towards our target of 3600 by 2019

 

R. Bulbulia, UK

Current status of the European Carotid Surgery Trial 2 (ECST-2)

 

M. Brown, UK

One-year results of SPACE-2

 

T. Reiff, Germany

Update on the North American RCTs CREST-2 and ACST-1 – will carotid artery stenting (CAS) survive as an alternative to BMT or CEA?

 

F. Veith, USA

Individual patient data meta-analyses of the immediate vs
deferred CEA trials with 6000 asymptomatic patients from VA, ACAS and ACST-1

 

A. Halliday, UK

10.00-11.00

MCC 2
Asymptomatic carotid stenosis II: medical therapy and natural history

 

Chairs:
H. Poppert, Germany
C. Zeebregts,The Netherlands

Defining “Best Medical Therapy” for asymptomatic carotid disease: potential benefits and limitations

 

R. Bulbulia, UK

Clinical risk factors and plaque characteristics associated with new development of contralateral stenosis in patients undergoing CEA

 

S. Merckelbach*,
The Netherlands

Is the risk of stroke in asymptomatic carotid disease so low that risk stratification (including calcification) is meaningless?

 

H. Sillesen, Denmark

The natural history of carotid occlusions

 

M. Brown, UK

Debate: The stroke risk of asymptomatic carotid stenoses is neglectable under best medical treatment – any intervention is useless and potentially harmful

 

 

 

Pro: Yes, of course, the evidence from prospective registries is overwhelming, CEA and CAS are useless and potentially harmful for the patients!

 

A. Abbott, Australia

 

Contra: Nonsense, the incidence of carotid-related strokes is still very high with thousands of patients being asymptomatic before the stroke occurred!

 

C. Liapis, Greece

 
11.00-11.30
COFFEE BREAK
 

11.30-12.30

MCC 3
Hot topics in carotid interventions (CEA)

 

Chairs:
T. Schmitz-Rixen, Germany
I. van Herzeele, Belgium

Carotid surgery in octogenarian women?

 

T. Cohnert, Austria

Symptomatic carotid revascularization: the volume of cerebral ischemic lesion predicts the outcome

 

A. Stella, Italy

Influence of metabolic syndrome on the short and long-term outcome after CEA

 

C. Zeebregts, The Netherlands

Value of troponin measurements in carotid artery revascularization

 

G. de Borst, The Netherlands

The vertebral artery – a forgotten vessel

 

K. Mathias, Germany

Technical factors associated with the in-hospital risk of stroke or death following CEA or CAS in German routine practice

 

C. Knappich*, Germany

12.30-12.45

Special lecture: Dealing with adversity: a requirement for success in vascular surgery

 

F. Veith, USA

 
12.45-13.45
LUNCH BREAK
 

13.45-14.50

MCC 4
Carotid Stenosis Trialists Collaboration (CSTC) session

 

Chairs:
M. Brown, UK
A. Halliday, UK
P. Ringleb, Germany

 

Keynote lecture: Rationale of the CSTC and fruits of this international collaboration

 

A. Algra, The Netherlands

How does age and sex affect stroke and mortality rates?

 

L. Bonati, Switzerland

The impact of timing of treatment on the outcomes of CAS and CEA – results from 4 randomized controlled trials

 

B. Rantner, Austria

Long-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a pre-planned meta-analysis of individual patient data

 

D. Calvet, France

Surgical results in CREST, SPACE 1, ICSS and EVA 3 S

 

A. Kühnl, Germany

Critical comment: why randomised clinical trials do sometimes not keep the promise!

 

A. Abbott, Australia

14.50-15.45

MCC 5
New technologies to assess hemodynamic insufficiency and to prevent CAS-related microembolism

 

Chairs:
A. Dörfler, Germany

 

Cognitive effects of chronic cerebral hypoperfusion in patients with high-grade carotid stenosis

 

J. Göttler, Germany

How to reduce microembolisms during CAS and to avoid potential long-term effects on cognition

 

I. van Herzeele, Belgium

DW-MRI new white lesions in carotid interventions – are they relevant and will membrane mesh carotid stents prevent microembolism?

 

S. MacDonald, USA

The use of transcarotid artery stenting for complex arch anatomy – single center series and one-year outcomes

 

N. Leal, Spain

Patients unsuited for CAS – the view of a CAS pioneer

 

K. Mathias, Germany

 
15.45-16.10
COFFEE BREAK
 

16.10-17.05

MCC 6
Modern treatment of large artery ischemic strokes

 

Chairs:
P. Ringleb, Germany
C. Zimmer, Germany

Simultaneous treatment of carotid artery stenosis and acute stroke

 

A. Dörfler, Germany

Technological advances and perspectives in endovascular stroke treatment

 

T. Liebig, Germany

TICI, mTICI or AOL? – The relevance of angiographic revascularization grading in stroke thrombectomy

 

B. Friedrich, Germany

General anesthesia or sedation – what is better for brain-protection in endovascular thrombectomy?

 

S. Dridi, Germany

17.05-17.20

Special lecture:  Vascular surgery in East Timor or let's tech conventional vascular surgery to those who will truly profit 

 

E. Braganza, Germany

17.20-18.20

MCC 7
Advances in carotid plaque imaging

 

Chairs:
E. Bartels, Germany
U. Hedin, Sweden

Clinical value of carotid plaque imaging:
recent results (PARISK)

 

E. Kooi,
The Netherlands

Detecting vulnerable plaques in patients with ischemic stroke with contrast-enhanced ultrasonography (CEUS) compared to carotid MRI

 

M. Koch, Germany

Modern ultrasound assessment of carotid plaque burden

 

T. Stadlbauer, Germany

Will 3D-Ultrasound be of use for risk stratification in carotid disease?

 

H. Sillesen, Denmark

Advances in multispectral optoacoustic tomography (MSOT)

 

V. Ntziachristos, Germany

 
Lecture Hall Pavillon
 

13.45-15.45

Poster Session I
Aortic diseases
(with an introducing lecture from C. Dzsinich on "Options for late complications after surgery for aortic coarctation")

 

 

16.15-18.15

MAC 1
Computational fluid dynamics and Finite Element Analyses

 

Chairs:
M. Gee, Germany
W. Wall, Germany

Keynote lecture: Biomechanics of aortic walls in health and disease: state of the art and challenges ahead

 

G. Holzapfel, Austria

Understanding arterial wall mechanics via constituent-based modelling and high resolution imaging

 

N. Stergiopolous,
Switzerland

Vascular mechanobiology: growth and remodeling in the aorta in health and disease

 

C. Cyron, Germany

Contribution of mathematical models and biomechanical properties in predicting the risk of AAA rupture – the view of a vascular surgeon

 

N. Chakfe, France

Modeling, simulation and optimization of artificial blood pumps

 

M. Behr, Germany

 

Operating Room
 

15.00-16.30

VASCUTEK DEUTSCHLAND GmbH
Fenestrated anaconda™ – where flexibility matters: implantation training I

 

B. Bauz, Germany
B. Reutersberg, Germany

16.30-18.00

VASCUTEK DEUTSCHLAND GMBH
Fenestrated anaconda™ – where flexibility matters: implantation training II

 

B. Bauz, Germany
B. Reutersberg, Germany

 
Conference Room 1 (Workshops / Seminars)
 

09.00-10.00

MEDTRONIC GmbH
Directional atherectomy and antirestenotic therapy (DAART)

 

M. Lopatta, Germany

10.00-11.00

COOK DEUTSCHLAND GmbH
Planning, sizing and deployment of the Zenith® fenestrated AAA graft demystified

 

A. Zimmermann, Germany

 
11.00-11.30
COFFEE BREAK
 

11.30-12.30

Education and training in major amputation techniques in vascular surgery

 

M. Steinbauer, Germany

 
12.45-13.45
LUNCH BREAK
 

13.45-14.45

How to organize an AAA screening programme

 

M. Björck, Sweden
N. Sakalihasan, Belgium
T. Schmitz-Rixen, Germany

14.45-15.45

MENTICE AB
Hands on simulator training I

 

L. Lönn, Denmark

 
15.45-16.15
COFFEE BREAK
 

16.15-17.15

SPECTRANETICS DEUTSCHLAND GMBH
Atherectomy for calicfied peripheral lesions - indications

 

R. Ghotbi, Germany

17.15-18.15

BOLTON MEDICAL
Interactive planning of arch endografts with scallops

 

A. Zimmermann, Germany

 

*Abstract, competing for the MAC Award for the best oral presentation